Our Portfolio

JSW Lifesciences GmbH

Manfred Windisch, PhD | , Austria

Project Overview

  • Biotechnology/For Profit Organization Type
  • $260,000 Funding Amount
  • 1/2/02 — 4/22/04 Project Duration
  • Drug Discovery Program
  • Lead Optimization Therapeutic Stage
  • Closed Status

JSW Lifesciences GmbH

Manfred Windisch, PhD | , Austria

Development of a new treatment for Alzheimer's disease and Parkinson's disease using anti-aggregatory Beta-Synuclein derived peptides

GET IN TOUCH